Prognostic Significance of Blood-Based Baseline Biomarkers in Treatment-Resistant Depression: A Literature Review of Available Studies on Treatment Response

Major depressive disorder is a leading cause of disability worldwide and a major contributor to the overall global burden of disease. While there are several options for antidepressant treatment, only about 40–60% of patients respond to initial monotherapy, while 30–40% of patients may even show res...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkesoglou, Theano, Bargiota, Stavroula I., Iordanidou, Eleni, Vasiliadis, Miltiadis, Bozikas, Vasilios-Panteleimon, Agorastos, Agorastos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317233/
https://www.ncbi.nlm.nih.gov/pubmed/35884746
http://dx.doi.org/10.3390/brainsci12070940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317233/
https://www.ncbi.nlm.nih.gov/pubmed/35884746
http://dx.doi.org/10.3390/brainsci12070940

Ejemplares similares